Insight Molecular Diagnostics (IMDX) Cash & Equivalents Growth (3y) (2018 - 2026)
Insight Molecular Diagnostics (IMDX) Cash & Equivalents Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 9.06% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -20.26% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 42.38% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 15.43% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 11.37% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 14.02% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -12.51% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -14.97% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -58.12% |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | 0.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.76% |
| Mar 31, 2026 | 33.69% |
| Dec 31, 2025 | -16.64% |
| Sep 30, 2025 | -16.48% |
| Jun 30, 2025 | -18.47% |
| Mar 31, 2025 | 14.98% |
| Dec 31, 2024 | -36.00% |
| Sep 30, 2024 | -57.19% |
| Jun 30, 2024 | -41.52% |
| Mar 31, 2024 | -54.36% |
| Dec 31, 2023 | 9.71% |
| Sep 30, 2023 | 10.27% |
| Jun 30, 2023 | 1.19% |
| Mar 31, 2023 | -13.56% |
| Dec 31, 2022 | -5.61% |
| Sep 30, 2022 | 18.19% |
| Jun 30, 2022 | 7.76% |
| Mar 31, 2022 | -19.59% |
| Dec 31, 2021 | 60.07% |
| Sep 30, 2021 | 58.81% |